Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer

Two decades ago, Galectin-8 was described as a prostate carcinoma biomarker since it is only expressed in the neoplastic prostate, but not in the healthy tissue. To date, no biological function has been attributed to Galectin-8 that could explain this differential expression. In this study we silenc...

Descripción completa

Detalles Bibliográficos
Autor principal: Kotler, Mónica Lidia
Publicado: 2017
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_19492553_v8_n27_p44654_Gentilini
http://hdl.handle.net/20.500.12110/paper_19492553_v8_n27_p44654_Gentilini
Aporte de:
id paper:paper_19492553_v8_n27_p44654_Gentilini
record_format dspace
spelling paper:paper_19492553_v8_n27_p44654_Gentilini2023-06-08T16:32:40Z Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer Kotler, Mónica Lidia Anoikis resistance Galectins Metastasis Prostate cancer Tumour microenvironment galectin 8 messenger RNA uvomorulin actin filament animal experiment animal model animal tissue anoikis Article carcinogenesis cell adhesion cell aggregation cell migration cell proliferation cell survival circulating tumor cell controlled study endothelium cell filopodium human human cell inguinal lymph node lymph node metastasis male metastasis mouse nonhuman prostate cancer prostate cancer cell line protein expression Two decades ago, Galectin-8 was described as a prostate carcinoma biomarker since it is only expressed in the neoplastic prostate, but not in the healthy tissue. To date, no biological function has been attributed to Galectin-8 that could explain this differential expression. In this study we silenced Galectin-8 in two human prostate cancer cell lines, PC3 and IGR-CaP1, and designed a pre-clinical experimental model that allows monitoring the pathology from its early steps to the long-term metastatic stages. We show for the first time that the natural and conserved expression of Gal-8 in tumour cells is responsible for the metastatic evolution of prostate cancer. In fact, Gal-8 controls the rearrangement of the cytoskeleton and E-Cadherin expression, with a major impact on anoikis and homotypic aggregation of tumour cells, both being essential processes for the survival of circulating tumour cells during metastasis. While localized prostate cancer can be cured, metastatic and advanced disease remains a significant therapeutic challenge, urging for the identification of prognostic markers of the metastatic process. Collectively, our results highlight Galectin-8 as a potential target for anti-metastatic therapy against prostate cancer. Fil:Kotler, M.L. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. 2017 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_19492553_v8_n27_p44654_Gentilini http://hdl.handle.net/20.500.12110/paper_19492553_v8_n27_p44654_Gentilini
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Anoikis resistance
Galectins
Metastasis
Prostate cancer
Tumour microenvironment
galectin 8
messenger RNA
uvomorulin
actin filament
animal experiment
animal model
animal tissue
anoikis
Article
carcinogenesis
cell adhesion
cell aggregation
cell migration
cell proliferation
cell survival
circulating tumor cell
controlled study
endothelium cell
filopodium
human
human cell
inguinal lymph node
lymph node metastasis
male
metastasis
mouse
nonhuman
prostate cancer
prostate cancer cell line
protein expression
spellingShingle Anoikis resistance
Galectins
Metastasis
Prostate cancer
Tumour microenvironment
galectin 8
messenger RNA
uvomorulin
actin filament
animal experiment
animal model
animal tissue
anoikis
Article
carcinogenesis
cell adhesion
cell aggregation
cell migration
cell proliferation
cell survival
circulating tumor cell
controlled study
endothelium cell
filopodium
human
human cell
inguinal lymph node
lymph node metastasis
male
metastasis
mouse
nonhuman
prostate cancer
prostate cancer cell line
protein expression
Kotler, Mónica Lidia
Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer
topic_facet Anoikis resistance
Galectins
Metastasis
Prostate cancer
Tumour microenvironment
galectin 8
messenger RNA
uvomorulin
actin filament
animal experiment
animal model
animal tissue
anoikis
Article
carcinogenesis
cell adhesion
cell aggregation
cell migration
cell proliferation
cell survival
circulating tumor cell
controlled study
endothelium cell
filopodium
human
human cell
inguinal lymph node
lymph node metastasis
male
metastasis
mouse
nonhuman
prostate cancer
prostate cancer cell line
protein expression
description Two decades ago, Galectin-8 was described as a prostate carcinoma biomarker since it is only expressed in the neoplastic prostate, but not in the healthy tissue. To date, no biological function has been attributed to Galectin-8 that could explain this differential expression. In this study we silenced Galectin-8 in two human prostate cancer cell lines, PC3 and IGR-CaP1, and designed a pre-clinical experimental model that allows monitoring the pathology from its early steps to the long-term metastatic stages. We show for the first time that the natural and conserved expression of Gal-8 in tumour cells is responsible for the metastatic evolution of prostate cancer. In fact, Gal-8 controls the rearrangement of the cytoskeleton and E-Cadherin expression, with a major impact on anoikis and homotypic aggregation of tumour cells, both being essential processes for the survival of circulating tumour cells during metastasis. While localized prostate cancer can be cured, metastatic and advanced disease remains a significant therapeutic challenge, urging for the identification of prognostic markers of the metastatic process. Collectively, our results highlight Galectin-8 as a potential target for anti-metastatic therapy against prostate cancer.
author Kotler, Mónica Lidia
author_facet Kotler, Mónica Lidia
author_sort Kotler, Mónica Lidia
title Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer
title_short Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer
title_full Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer
title_fullStr Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer
title_full_unstemmed Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer
title_sort stable and high expression of galectin-8 tightly controls metastatic progression of prostate cancer
publishDate 2017
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_19492553_v8_n27_p44654_Gentilini
http://hdl.handle.net/20.500.12110/paper_19492553_v8_n27_p44654_Gentilini
work_keys_str_mv AT kotlermonicalidia stableandhighexpressionofgalectin8tightlycontrolsmetastaticprogressionofprostatecancer
_version_ 1768542103116185600